Graham Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31,334	Closed	-$943K	–	1551
2025 Q3	$943K	Sell	31,334 -78,754	-72%	-$2.36M	0.03%	404
2025 Q2	$4M	Buy	110,088 +30,612	+39%	+$1.1M	0.12%	183
2025 Q1	$2.88M	Buy	79,476 +20,347	+34%	+$846K	0.09%	229
2024 Q4	$2.49M	Buy	59,129 +16,128	+38%	+$800K	0.08%	246
2024 Q3	$2.39M	Sell	43,001 -12,572	-23%	-$640K	0.08%	238
2024 Q2	$2.28M	Buy	55,573 +11,538	+26%	+$493K	0.08%	218
2024 Q1	$2.06M	Buy	44,035 +30,175	+218%	+$1.42M	0.06%	249
2023 Q4	$663K	Buy	+13,860	New	+$537K	0.02%	502
2022 Q4	–	Sell	-5,936	Closed	-$245K	–	1296
2022 Q3	$245K	Buy	+5,936	New	+$305K	0.01%	957